KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Equity Average: 2020-2025

Historic Equity Average for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $586.4 million.

  • Ginkgo Bioworks Holdings' Equity Average fell 28.10% to $586.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $586.4 million, marking a year-over-year decrease of 28.10%. This contributed to the annual value of $906.6 million for FY2024, which is 36.01% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Equity Average of $586.4 million as of Q3 2025, which was down 6.95% from $630.2 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Equity Average's 5-year high stood at $1.7 billion during Q1 2023, with a 5-year trough of $375.7 million in Q2 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Equity Average averaged around $1.0 billion, with its median value being $910.2 million (2024).
  • Its Equity Average has fluctuated over the past 5 years, first soared by 324.77% in 2022, then crashed by 41.49% in 2024.
  • Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Equity Average stood at $1.6 billion in 2021, then fell by 0.16% to $1.6 billion in 2022, then dropped by 26.11% to $1.2 billion in 2023, then slumped by 35.57% to $757.0 million in 2024, then dropped by 28.10% to $586.4 million in 2025.
  • Its Equity Average stands at $586.4 million for Q3 2025, versus $630.2 million for Q2 2025 and $681.7 million for Q1 2025.